Barclays has raised its recommendation on Keurig Dr Pepper, moving the stock to Overweight from Equal Weight while boosting its price target to $36 from $30. The firm attributes the change to a combination of stronger leverage metrics, less uncertainty around the recent transactions, and greater clarity about management's planned corporate separation.
In its assessment, Barclays described Keurig Dr Pepper as an uncommon valuation opportunity within the consumer staples space. The broker argued that investors may re-evaluate the company's fundamentals positively as the planned split between its beverage operations and coffee assets becomes more defined.
Management clarifications have reduced investor concerns
Barclays said a number of investor worries that arose after the acquisition of JDE Peet's and the announced separation have eased over the last nine months. According to the broker, management has provided clearer details on several critical items - including financing arrangements for the transaction, how the separation will be executed, and governance structures for the distinct businesses - which collectively have helped to de-risk the overall plan and bolster confidence in the strategic direction.
Execution risks persist, but growth profile remains strong
The brokerage acknowledged that execution risks remain. It specifically flagged ongoing integration work tied to JDE Peet's, preparations required to effect the separation, and the company's search for a new chief executive for the planned Global Coffee Co. Despite these operational challenges, Barclays continues to view Keurig Dr Pepper as offering one of the more attractive growth profiles in its coverage universe and maintains that the strategic rationale for separating beverage and coffee businesses remains sound.
Valuation frameworks point above current trading
Barclays' sum-of-the-parts analysis indicates the shares are trading below where they should be, in the broker's view. Using an EV/EBITDA framework, Barclays calculates an implied equity value near $35 per share. A separate P/E-based approach yields an implied equity value of roughly $37 per share. Both estimates sit above the stock's recent trading level of $30.87.
Outlook for the two standalone businesses
The broker expects the standalone Beverage Co. to benefit from being a pure-play liquid refreshment beverage company. For the coffee side, Barclays believes the combination of Keurig and JDE Peet's will give the planned Global Coffee Co. meaningful scale and diversification. The firm further stated that, despite some investor skepticism, it believes the coffee business can emerge as one of the world's largest coffee platforms with exposure across formats and geographies.
Earnings and synergy assumptions
Barclays left its earnings estimates intact, projecting adjusted earnings per share of $2.30 for 2026 and $2.52 for 2027. The broker also highlighted potential upside from revenue synergies, digital marketing initiatives, and a three-year $400 million synergy program tied to integrating JDE Peet's.
ProPicks AI note
The article also included a description of an AI-based stock evaluation tool, noting that it assesses companies using numerous financial metrics and has identified prior winners. That section characterizes the tool as unbiased in its identification of stock ideas based on current data.